⌘K
Loading ticker…
NanoViricides Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, NanoViricides Inc. (NNVC) has a 3-month relative strength percentile of 86 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 54. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.5%, relative volume 0.34×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 86, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
NNVC is in a stage 1 base, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -6.8% / 4.1%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
NNVC is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $314K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $314K |
| VXFVanguard Extended Market ETF | 0.00% | $152K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NNVC Jan avg: 1.43% median: -2.89% win: 50% σ: 20.83% n: 4 2022-04-12 → 2026-05-29 | NNVC Feb avg: 9.51% median: 9.40% win: 75% σ: 9.81% n: 4 2022-04-12 → 2026-05-29 | NNVC Mar avg: -13.45% median: -13.60% win: 0% σ: 1.63% n: 4 2022-04-12 → 2026-05-29 | NNVC Apr avg: 9.28% median: 13.47% win: 80% σ: 21.82% n: 5 2022-04-12 → 2026-05-29 | NNVC May avg: 33.53% median: 34.23% win: 80% σ: 44.75% n: 5 2022-04-12 → 2026-05-29 | NNVC Jun avg: -8.18% median: -6.95% win: 25% σ: 15.54% n: 4 2022-04-12 → 2026-05-29 (current) | NNVC Jul avg: 18.51% median: 21.23% win: 75% σ: 16.45% n: 4 2022-04-12 → 2026-05-29 | NNVC Aug avg: 0.03% median: -8.50% win: 25% σ: 21.10% n: 4 2022-04-12 → 2026-05-29 | NNVC Sep avg: -13.85% median: -15.33% win: 25% σ: 14.07% n: 4 2022-04-12 → 2026-05-29 | NNVC Oct avg: -1.21% median: -2.62% win: 25% σ: 13.17% n: 4 2022-04-12 → 2026-05-29 | NNVC Nov avg: -9.30% median: -6.23% win: 25% σ: 12.13% n: 4 2022-04-12 → 2026-05-29 | NNVC Dec avg: -10.93% median: -9.34% win: 25% σ: 14.63% n: 4 2022-04-12 → 2026-05-29 |